These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37364691)

  • 1. Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis.
    He Y; Xi J; Fang J; Zhang B; Cai W
    Free Radic Biol Med; 2023 Sep; 206():13-21. PubMed ID: 37364691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway.
    Xue S; Chen H; Zhang J; Tian R; Xie C; Sun Q; Wang H; Shi T; Guo D; Wang Y; Wang Q
    J Ethnopharmacol; 2024 Dec; 335():118604. PubMed ID: 39047881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
    Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
    Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
    Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation.
    Zhang H; Pan J; Huang S; Chen X; Chang ACY; Wang C; Zhang J; Zhang H
    Redox Biol; 2024 Apr; 70():103066. PubMed ID: 38359744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis
    Lin Z; Wu C; Song D; Zhu C; Wu B; Wang J; Xue Y
    Redox Rep; 2024 Dec; 29(1):2392329. PubMed ID: 39150892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
    Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
    FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via Nrf2/GPX4 pathway.
    Wang Y; Han J; Zhan S; Guo C; Yin S; Zhan L; Zhou Q; Liu R; Yan H; Wang X; Yan D
    Int J Biol Macromol; 2024 Sep; 276(Pt 1):133792. PubMed ID: 38992539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways.
    Lu Z; Liu Z; Fang B
    Bioengineered; 2022 Apr; 13(4):9145-9155. PubMed ID: 35363601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
    Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
    Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through the remodeling of gut microbiota composition.
    Hu S; Zhou J; Hao J; Zhong Z; Wu H; Zhang P; Yang J; Guo H; Chi J
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C161-C176. PubMed ID: 38009195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes.
    Mao M; Zheng W; Deng B; Wang Y; Zhou D; Shen L; Niku W; Zhang N
    PLoS One; 2023; 18(10):e0292124. PubMed ID: 37824478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrine induces cardiotoxicity by promoting ferroptosis through the Nrf2 antioxidant system in H9c2 cells.
    Wang X; Lin Z; Tang X; Xie M; Li T; Zhou J
    Toxicol Lett; 2024 Jun; 397():11-22. PubMed ID: 38723914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
    Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.
    Sun X; Sun P; Zhen D; Xu X; Yang L; Fu D; Wei C; Niu X; Tian J; Li H
    Toxicol Appl Pharmacol; 2022 Feb; 437():115902. PubMed ID: 35093381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.